Fulgent Genetics (FLGT) Return on Invested Capital (2021 - 2023)

Fulgent Genetics has reported Return on Invested Capital for 3 years, with the latest figure at 0.08% in Q4 2023.

• Quarterly Return on Invested Capital fell 11.0% year-over-year to 0.08% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 0.08% (down 11.0% YoY) and the FY2022 annual result came in at 0.09%, down 24.0% from the prior year.
• Return on Invested Capital slipped to 0.08% in Q4 2023 per FLGT's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.19% in Q1 2021 and troughed at 0.08% in Q4 2023.
• A 3-year average of 0.05% and a median of 0.05% in 2022 frame the typical range for Return on Invested Capital.
• The widest YoY moves for Return on Invested Capital: up 5 bps in 2022, down 11 bps in 2022.
• Over 3 years, Return on Invested Capital stood at 0.08% in 2021, then tumbled by 64 bps to 0.03% in 2022, then plunged by 374 bps to 0.08% in 2023.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.08%, 0.01%, and 0.0% for Q4 2023, Q3 2023, and Q2 2023 respectively.